Zota Health Care Limited (ZOTA.NS)

INR 770.0

(0.82%)

Operating Income Summary of Zota Health Care Limited

  • Zota Health Care Limited's latest annual operating income in 2023 was -129.79 Million INR , down -227.43% from previous year.
  • Zota Health Care Limited's latest quarterly operating income in 2024 Q1 was -92.82 Million INR , down -12.05% from previous quarter.
  • Zota Health Care Limited reported an annual operating income of -38.27 Million INR in 2022, down -134.16% from previous year.
  • Zota Health Care Limited reported an annual operating income of 112.04 Million INR in 2021, up 626.3% from previous year.
  • Zota Health Care Limited reported a quarterly operating income of -125.3 Million INR for 2023 FY, down -227.43% from previous quarter.
  • Zota Health Care Limited reported a quarterly operating income of -82.83 Million INR for 2023 Q4, down -374.42% from previous quarter.

Annual Operating Income Chart of Zota Health Care Limited (2023 - 2010)

Historical Annual Operating Income of Zota Health Care Limited (2023 - 2010)

Year Operating Income Operating Income Growth
2023 -129.79 Million INR -227.43%
2022 -38.27 Million INR -134.16%
2021 112.04 Million INR 626.3%
2020 -21.28 Million INR -184.07%
2019 25.32 Million INR -60.89%
2018 64.74 Million INR -43.56%
2017 114.7 Million INR 27.19%
2016 90.18 Million INR 7.1%
2015 84.2 Million INR 21.18%
2014 69.49 Million INR 29.56%
2013 53.63 Million INR 18.19%
2012 45.38 Million INR 0.0%
2010 34.24 Million INR 0.0%

Peer Operating Income Comparison of Zota Health Care Limited

Name Operating Income Operating Income Difference
Biocon Limited 50.83 Billion INR 100.255%
Blue Jet Healthcare Limited 3.37 Billion INR 103.849%
Concord Biotech Limited 6.26 Billion INR 102.073%
Dishman Carbogen Amcis Limited -413 Million INR 68.572%
Jubilant Ingrevia Limited 2.93 Billion INR 104.415%
Lyka Labs Limited 29.13 Million INR 545.575%
Panacea Biotec Limited - INR Infinity%
Piramal Pharma Limited 4.31 Billion INR 103.008%
SMS Lifesciences India Limited 359.47 Million INR 136.107%
Supriya Lifescience Limited 1.57 Billion INR 108.259%
Syngene International Limited 6.46 Billion INR 102.007%
TAKE Solutions Limited -213.49 Million INR 39.203%